Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2020-04-17

Clinical Trial Update: The Impact of Venlafaxine on Apnea Hypopnea Index in Obstructive Sleep Apnea [Phase 4]

View source ↗

Summary

Phase 4 trial evaluating the impact of venlafaxine on apnea-hypopnea index in obstructive sleep apnea has completed with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Venlafaxine (Venlafaxine)

Snippet

Sponsor: University of California, San Diego | Conditions: Obstructive Sleep Apnea | Phase 4 | Status: COMPLETED | Results posted: 2020-04-17